Purpose of the development: Immunoassay using recombinant proteins in Mycobacterium ekspressovannyh Escherichia Coli intended to diagnose tuberculosis.

Recommended application field: Medicine. Pharmacology.

Advantages over analogues: Development of diagnostic tests using the recombinant proteins of Mycobacterium is promising due to their effectiveness, low cost and safety.

The development stage readiness: Ready for application

Description of the development:
()
Proteins MRT63 MRT83 and Mycobacterium tuberculosis can be used to develop immunodiagnostic reagents because of their high immunogenicity. The diagnostic test is based on an extremely rapid immunochemical method - immunochromatography on a nitrocellulose membrane . The test comprises applying the antigens on a nitrocellulose membrane, and further development with antibodies to these antigens with colloidal gold particles . The method allows to obtain specific results in just a few minutes. Another promising approach is to develop a semi-quantitative immunoassay test. The result of this test indicates not only the presence or absence of an immune response , but also makes it possible to evaluate the quality.

corresponds technical description
Ready for implementation

Possibility of transfer abroad:
Licence's sale
Licence's sale
Creation of joint enterprise
Realization of finished commodity

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua